T1	Condition 18 31	other cancers
T2	Temporal 32 48	at the same time
R1	Has_temporal Arg1:T1 Arg2:T2	
T3	Condition 72 85	other cancers
T4	Negation 86 92	except
T5	Condition 93 129	controlled skin basal cell carcinoma
T6	Condition 133 161	skin squamous cell carcinoma
T7	Condition 165 199	carcinoma in situ of cervix uterus
*	OR T5 T6 T7
T8	Scope 93 199	controlled skin basal cell carcinoma or skin squamous cell carcinoma or carcinoma in situ of cervix uterus
R2	Has_negation Arg1:T8 Arg2:T4	
R3	Has_scope Arg1:T3 Arg2:T8	
*	OR T1 T3
T9	Temporal 220 226	active
T10	Condition 227 237	infections
T11	Negation 248 251	not
T12	Qualifier 252 277	suitable for chemotherapy
R4	Has_negation Arg1:T12 Arg2:T11	
R5	Has_qualifier Arg1:T10 Arg2:T12	
R6	Has_temporal Arg1:T10 Arg2:T9	
T13	Qualifier 298 304	severe
T14	Condition 305 327	non-cancerous diseases
R7	Has_qualifier Arg1:T14 Arg2:T13	
T15	Procedure 359 386	neoadjuvant hormone therapy
T16	Condition 407 431	bilateral breast cancers
T17	Condition 435 439	DCIS
T18	Condition 443 468	metastatic breast cancers
*	OR T18 T17 T16
T19	Procedure 525 546	anti-cancer therapies
T20	Observation 555 586	attending other clinical trials
*	OR T19 T20
T21	Condition 606 614	pregnant
T22	Condition 618 629	lactational
*	OR T22 T21 T23
T23	Procedure 658 671	contraception
T24	Negation 639 657	refuse to practice
R8	Has_negation Arg1:T23 Arg2:T24	
T25	Temporal 672 694	during the whole trial
R9	Has_temporal Arg1:T23 Arg2:T25	
T26	Post-eligibility 697 835	The patients are in some special conditions that they can't understand the written informed consent, such as they are demented or hawkish.
T27	Condition 855 863	allergic
T28	Drug 895 904	tamoxifen
T29	Condition 875 891	contraindication
*	OR T29 T27
T30	Scope 855 891	allergic history or contraindication
R10	AND Arg1:T30 Arg2:T28	
